Falsified Medical Product Alert N°9/2019
Augmentin (amoxicillin trihydrate and potassium clavulanate): falsified product alert
WHO issued this alert after the Uganda National Drug Authority found falsified Augmentin at patient level through routine post-marketing surveillance. The Kenya Pharmacy and Poisons Board confirmed the same batch had previously been found in Kenya. Testing found none of the expected active ingredients.1
- Issued
- 20 August 2019
- Issued by
- World Health Organization
- Name stated on packaging
- Packaging bears the Augmentin brand. WHO did not name the company shown on the falsified packs in the text.
- Genuine manufacturer's statement
- WHO said the stated manufacturer confirmed it did not make this falsified version.
- Countries where detected
- Uganda, Kenya
Batches named in the alert
Listed in Table 1 of the alert
Advice as stated
Do not use the listed products. Anyone who has taken them or had an adverse event or lack of efficacy should seek advice from a health professional and report it to the national authorities. Obtain medical products only from authentic and reliable sources.
Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.
Sources
- World Health Organization, Medical Product Alert N°9/2019: Falsified Augmentin (20 August 2019)